The Operating System for Investing

Act as a senior macro economist and equity strategist covering Indian markets.
Give me a complete macro intelligence briefing for [MONTH + YEAR].

1. GROWTH ENVIRONMENT
   - India GDP growth: latest actual + next quarter outlook
   - Manufacturing PMI: last 3 months trend (above or below 50?)
   - Services PMI: last 3 months trend
   - GST collections: latest month figure + YoY growth %
   - IIP (Index of Industrial Production): latest reading + trend

2. MONETARY ENVIRONMENT
   - RBI Repo Rate: current level
   - Next MPC meeting direction: likely HIKE / CUT / HOLD and why
   - 10-year G-Sec yield: current + 3-month trend
   - Bank credit growth: latest YoY %

3. INFLATION AND CURRENCY
   - CPI inflation: latest + 3-month trend
   - WPI inflation: latest reading
   - INR vs USD: current level + 3-month trend + impact on import costs
   - Brent crude price: current + trend + India impact

4. FISCAL AND POLICY
   - Fiscal deficit vs budget estimate: on track?
   - Major government spending announcements in last 30 days
   - Any new PLI schemes, tariff changes, or sector policies announced

5. MARKET FLOWS
   - FII net equity flows: last 30 days total (Rs. Crores)
   - DII net equity flows: last 30 days total (Rs. Crores)
   - Overall market sentiment: RISK-ON / RISK-OFF / NEUTRAL

FINAL OUTPUT (required):
- Rate the overall macro environment: BULLISH / NEUTRAL / BEARISH for Indian equities
- Top 3 sectors most favored in this macro environment (with one-line reasoning each)
- Top 3 sectors facing maximum headwinds (with one-line reasoning each)
- Overall verdict: Should I DEPLOY capital aggressively, DEPLOY selectively, HOLD, or RAISE CASH?
- Key macro risk to watch in the next 30 days

Analyse institutional investor activity in Indian equity markets for [QUARTER e.g. Q2 FY25].

1. MUTUAL FUND (DII) ACTIVITY
   - Net MF equity buying/selling this quarter: total amount in Rs. Crores
   - Top 5 sectors where mutual funds INCREASED exposure (with approximate amount)
   - Top 5 individual stocks with LARGEST increase in mutual fund holding %
   - Which MF categories saw highest net inflows? (Small/Mid/Large cap, sectoral)
   - Any new NFOs launched and what theme do they target?

2. FII (FOREIGN INSTITUTIONAL INVESTOR) ACTIVITY
   - Net FII equity flows this quarter: total in Rs. Crores
   - Which sectors are FIIs overweight vs underweight vs last quarter?
   - Top 5 stocks with largest FII holding INCREASE
   - Top 5 stocks with largest FII holding DECREASE (potential exit signal)
   - Is India overweight or underweight in global EM allocations currently?

3. HIGH CONVICTION INSTITUTIONAL SIGNAL (most important section)
   Find stocks matching ALL of these simultaneously:
   - DII holding increased by more than 2% in BOTH of the last 2 quarters
   - Promoter holding is greater than 50% (low public float)
   - FII holding is less than 8% (institutions haven't fully discovered it)
   - Market cap is less than Rs. 8,000 Crores (still small enough to move)
   
   List all matching stocks with: company name, NSE ticker, brief business description,
   exact DII holding change, promoter %, FII %, market cap

4. DIVERGENCE SIGNALS
   - Stocks where DII is aggressively BUYING but FII is SELLING (DII ahead of FII?)
   - Stocks where BOTH DII and FII are simultaneously increasing (consensus buy)

OUTPUT: A prioritized list of 15-20 stock names from this institutional analysis.
For each: Company name, NSE ticker, sector, specific institutional signal, conviction level.

I need a complete sector rotation analysis for Indian equities as of [DATE].

CURRENT MACRO CONTEXT (fill in from your TD-1 output):
- GDP Growth: [X]%
- Rate Cycle: [Rising / Falling / Stable]
- Inflation: [X]%
- FII Flows last 30 days: [Net Buyer / Net Seller]
- Crude Oil: [Price and trend — Rising / Falling / Stable]

For each sector below, tell me:
(a) Current cycle phase: EARLY EXPANSION / MID EXPANSION / LATE EXPANSION / CONTRACTION / TROUGH / RECOVERY
(b) Current momentum: ACCELERATING / STABLE / DECELERATING
(c) Your rating: OVERWEIGHT / NEUTRAL / UNDERWEIGHT / AVOID
(d) One specific reason supporting your rating
(e) Top 2 listed Indian companies best positioned right now

SECTORS TO COVER:
1. Private Banks + NBFCs
2. IT Services — Large Cap (TCS, Infosys type)
3. IT Services — Mid/Small Cap
4. Pharma + Healthcare (domestic focus)
5. Pharma + Healthcare (export / CDMO focus)
6. FMCG + Consumer Staples
7. Consumer Discretionary (Auto, Retail, QSR, Durables)
8. Capital Goods + Engineering + Defence
9. Infrastructure + Construction + Cement
10. Metals + Mining
11. Specialty Chemicals
12. Real Estate
13. Renewable Energy + EV
14. Financial Services (Insurance, Wealth, Exchanges)

ROTATION RECOMMENDATIONS:
- OVERWEIGHT sectors (list with reasoning): 
- UNDERWEIGHT sectors (list with reasoning):
- Key rotation trade: Move FROM [sector] TO [sector] because [specific reason]

OUTPUT FORMAT: First give the full sector table, then a clean list of top 10 stock ideas
from your OVERWEIGHT sectors with ticker symbols.

Identify all current structural investment themes in India offering multi-year (5-10 year) opportunities.
A structural theme is different from a cyclical one — it persists regardless of economic cycles.

For each structural theme provide ALL of the following:

1. THEME NAME + one-sentence thesis
2. WHAT IS DRIVING IT: Government policy / Demographics / Global trend / Technology shift
3. SPECIFIC GOVERNMENT SUPPORT: Name the exact scheme, budget allocation amount, and timeline
4. MARKET OPPORTUNITY SIZE: Current market in Rs. Crores + projected in 5 years + implied CAGR
5. STAGE OF THEME: 
   - EARLY (maximum upside, higher risk — theme still being discovered)
   - DEVELOPING (good risk/reward — theme confirmed, companies scaling)  
   - MATURE (lower upside, safer — theme well-known, priced in)
6. LISTED INDIAN BENEFICIARIES:
   - Pure play (100% revenue from this theme): company + ticker
   - High exposure (50-80% revenue): company + ticker
   - Partial exposure (20-50% revenue): company + ticker

THEMES TO ANALYSE (minimum coverage):
- Defence manufacturing + indigenisation (Make in India Defence)
- PLI-linked manufacturing (Electronics, Solar panels, Pharma APIs, Chemicals)
- Data centres + Digital infrastructure buildout
- Electric vehicles + EV component supply chain
- Healthcare + hospital chains + diagnostics
- Agrochemicals + specialty food processing
- China+1 export-oriented manufacturing
- Water infrastructure + waste management
- Financial inclusion + insurance penetration in Tier 2/3 cities
- Semiconductor + electronics design/manufacturing

FINAL OUTPUT: Rank all themes 1 to 10 by risk-adjusted return potential over 3 years.
For the top 5 ranked themes, give me a specific stock pick with a one-line thesis for each.

I have completed my top-down analysis. Now build me a consolidated company list for research.

MY TOP-DOWN ANALYSIS SUMMARY:
[Paste your TD-1 macro verdict here — 2-3 sentences]

MY SECTOR ROTATION PICKS (from TD-3):
- Overweight sectors: [list them]

MY STRUCTURAL THEMES (from TD-4):
- Top themes: [list top 2-3]

MY INSTITUTIONAL SIGNALS (from TD-2):
- High-conviction institutional picks: [paste list]

YOUR TASK:
Step 1: For each overweight sector I listed, give me the 5 best-positioned listed Indian
        companies — do NOT just give the most obvious large caps. Include quality mid-caps
        that most retail investors have not discovered yet.

Step 2: For each structural theme I listed, give me 3-4 companies with the strongest
        direct exposure to that theme.

Step 3: Combine all companies from Step 1 and Step 2 into one master list.
        Remove exact duplicates. Keep a company if it appears in multiple themes
        (that is actually a stronger signal — mark it with a [MULTI-THEME] tag).

Step 4: Remove from the list any company that has:
        - Market cap below Rs. 150 Crores (too illiquid)
        - Revenue declining in the last full financial year
        - Any governance scandal or SEBI action in the last 3 years

Step 5: Add my institutional signal picks to the final list (if not already present).

FOR EVERY COMPANY IN THE FINAL LIST, PROVIDE THIS FORMAT:
| Company Name | NSE Ticker | Market Cap (approx Cr) | Sector | Theme Tag | Why it fits | Source of idea |

TARGET: A clean table of 25-35 companies ready for Stage 2 shortlisting.
Sort by: conviction level (High / Medium / Low) then alphabetically within each level.

I ran a stock screener on Screener.in and got the following results.
Validate each company before I spend research time on it.

SCREENER I USED: [Name — e.g., DII Buying + Low Float]
SCREENER CRITERIA: [Paste the exact formula]
OUTPUT COMPANIES: [Paste the full list of company names from Screener.in]

For every company in the list, check these 5 things quickly:
1. Is revenue growth real or a one-year spike? Check the 3-year trend — is it consistent?
2. Is ROCE above 15% in at least 2 of the last 3 years (not just one good year)?
3. Any negative news, governance issue, SEBI action, or pledging concern in the last 12 months?
4. What does this business actually do? (One sentence — simple and clear)
5. Rate this company: INVESTIGATE FURTHER / ADD TO WATCHLIST / SKIP / RED FLAG

After checking all companies:
- Immediately discard all RED FLAG companies
- Rank the remaining companies 1 to 10 on: business clarity + financial consistency + theme relevance
- For the top 5 ranked companies: give me 3 specific things to check when I research them further

OUTPUT FORMAT: 
| Rank | Company | Ticker | Verdict | Score (1-10) | Reason | 3 things to investigate |

Find me 10-12 genuinely undiscovered Indian companies with excellent fundamentals
that the market has NOT yet priced correctly.

HARD CRITERIA (every company must pass ALL of these):
- Market cap: Rs. 200 Crores to Rs. 6,000 Crores only
- Revenue CAGR over the last 3 years: greater than 18%
- ROCE: greater than 18% in at least 2 of the last 3 years
- Debt-to-Equity ratio: less than 0.5x
- Promoter holding: greater than 50%
- NOT in Nifty 500 index (genuinely small / undiscovered)
- Total mutual fund holding less than 8% (institutions have not fully found it)

For each company you find, provide:
1. Company name + NSE ticker + approximate market cap
2. Exactly what they sell and who they sell it to (be specific — no vague descriptions)
3. Why is this company still undiscovered? 
   (Small size? Boring sector? No investor relations? Niche product?)
4. The specific growth driver: what will double or triple revenue in the next 3-5 years?
5. Financial evidence: exact revenue CAGR, ROCE trend, and current EBITDA margin
6. The key risk: what is the ONE thing that could go wrong?
7. Where to find more information: Annual report source, any available concall transcripts?

IMPORTANT RULE: Quality over quantity. I would rather have 7 excellent companies 
than 12 uncertain ones. Only include companies you can confidently defend.

OUTPUT: Sorted by quality score — best ideas first.

I am doing my weekly watchlist review. Here is my current Tier 1 watchlist:

[PASTE YOUR WATCHLIST TABLE — Company, Ticker, Fair Value, Entry Price, Current CMP, MOS%, Thesis Status]

For each Tier 1 company, tell me:

1. PRICE ACTION CONTEXT
   Did the stock move more than 5% this week? If yes, what was the specific reason?
   (Check BSE filings, news, sector development)
   
2. THESIS CHECK
   Has anything happened this week that STRENGTHENS or WEAKENS the investment thesis?
   - Any management interview or investor presentation released?
   - Any regulatory development affecting this sector?
   - Any competitor results that give us read-through on industry trends?

3. BUY ZONE ALERT
   For any company where CMP is now below or within 5% of the entry target:
   - Confirm: Is the price drop due to sentiment (good — buy opportunity) or
     fundamentals (bad — re-examine thesis before buying)?
   - What is the specific action I should take this week?

4. SECTOR DEVELOPMENT CHECK
   Is there any macro or sector news this week that materially changes
   my view on any company in the list?

OUTPUT FORMAT:
For each company: one paragraph with (a) price context, (b) thesis status, (c) specific action.
End with a ranked list: which 1-2 companies are closest to being actionable this week?

I am analysing [COMPANY NAME] (NSE: [TICKER]).
Here is their 10-year P&L data (paste from your P&L ANALYSIS sheet):

[PASTE YOUR P&L DATA — Revenue, Gross Profit, EBITDA, EBIT, PAT and all margin rows]

Analyse this income statement in detail:

1. REVENUE QUALITY
   - Revenue CAGR: compute 1Y, 3Y, 5Y, and 10Y. Is growth accelerating or decelerating?
   - Is growth volume-driven or price-driven? Which type is more durable and why?
   - Are there any irregular years? If so, explain exactly what caused the deviation.
   - Is revenue diversified across segments/geographies, or concentrated in one area?

2. MARGIN CASCADE ANALYSIS
   - Gross Margin: expanding, stable, or contracting over 5 years? Why?
   - From Gross to EBITDA: is employee cost growing faster or slower than revenue?
     (Faster than revenue = dis-economy; slower = operating leverage kicking in)
   - From EBITDA to EBIT: is depreciation growing at a faster rate than the asset base warrants?
     (Sudden spike in D&A = new plant commissioned; sudden fall = depreciation policy change — flag it)
   - From EBIT to PAT: is the interest burden shrinking? Is effective tax rate stable?

3. KEY DRIVER IDENTIFICATION
   - What is the SINGLE BIGGEST driver of profitability in this business?
   - What is the SINGLE BIGGEST risk to margins in the next 12 months?

4. EARNINGS QUALITY SIGNALS
   - Is Other Income material (> 10% of PBT)? If yes, what is it?
   - Are there exceptional items? Are they genuinely one-time?
   - Is the tax rate consistent? Any sudden drops that inflate PAT artificially?

5. FINAL P&L QUALITY RATING
   - Rate the P&L quality: EXCELLENT / GOOD / AVERAGE / POOR
   - List exactly 3 GREEN FLAGS from this P&L
   - List exactly 3 RED FLAGS or CONCERNS from this P&L
   - Overall: does this P&L make you MORE or LESS confident about investing?

I am analysing [COMPANY NAME] (NSE: [TICKER]).
Here is their 10-year balance sheet data:

[PASTE YOUR BALANCE SHEET DATA — all asset and liability rows]

Analyse the balance sheet in detail:

1. ASSET QUALITY ANALYSIS
   - Fixed asset trend: Is gross fixed asset growing proportionally with revenue?
     (Revenue growing faster than assets = capital-light efficiency. Assets growing faster = heavy capex cycle.)
   - CWIP: Is capital work-in-progress large? What % of gross block?
     (High CWIP = future depreciation and interest will rise. Warn me if > 25% of net fixed assets.)
   - Intangibles + Goodwill: What % of total assets? Has goodwill been impaired at any point?
     (Goodwill > 20% of assets = acquisition risk. Any impairment = management overpaid for acquisitions.)
   - Cash: Is cash genuinely free, or pledged / restricted? Is it growing or being consumed?

2. WORKING CAPITAL ANALYSIS
   - Calculate inventory days, debtor days, creditor days for each year
   - Cash Conversion Cycle trend: is it improving (shortening) or deteriorating (lengthening)?
   - Any sudden jumps in receivables or inventory without matching revenue growth?
     (Receivables growing faster than revenue for 2+ years = collection problem — flag it clearly)

3. DEBT AND SOLVENCY
   - Debt-to-Equity trend: is leverage increasing or decreasing over 5 years?
   - Nature of debt: is it project finance (acceptable) or working capital emergency (concern)?
   - Net Debt / EBITDA trend: is the business deleveraging?
   - Interest Coverage trend: is the company getting stronger or weaker on debt servicing?

4. BALANCE SHEET QUALITY RATING
   - Rate balance sheet strength: FORTRESS / HEALTHY / ADEQUATE / STRETCHED / DANGEROUS
   - Top 3 balance sheet strengths
   - Top 3 balance sheet risks
   - Would this balance sheet survive a 2-year revenue decline of 20%?

I am analysing [COMPANY NAME] (NSE: [TICKER]).
Here are their calculated ratios across 10 years:

[PASTE YOUR RATIO ANALYSIS SHEET DATA — all ratio rows]

Interpret these ratios in depth:

1. PROFITABILITY TREND INTERPRETATION
   - ROCE trend: is it consistently above 15%? Any years it fell below? What caused it?
   - ROE vs ROCE comparison: if ROE >> ROCE, the company is using leverage to boost returns.
     Is this leverage productive or dangerous?
   - Margin trend analysis: which specific cost line is causing margin expansion/contraction?

2. EFFICIENCY SIGNALS
   - Cash Conversion Cycle: is it negative (best — like D-Mart)? Or positive and worsening?
   - Asset turnover trend: improving = capital-light efficiency. Declining for 2+ years
     without a known capex cycle = operational problem.
   - Compare inventory days, debtor days, creditor days to the company's sector norm.
     Where is this company different from peers and why?

3. SOLVENCY RED FLAGS CHECK
   - Flag any year where Interest Coverage Ratio dropped below 3x
   - Flag any year where Debt/Equity exceeded 1.5x
   - Flag any year where Net Debt/EBITDA exceeded 3x
   - For each flagged year: was the reason temporary or structural?

4. CAPITAL ALLOCATION SCORE
   - CFO/PAT ratio: above 0.8 consistently = good earnings quality. Below 0.5 = flag it.
   - ROIC vs WACC (use 12% as WACC): is this company creating or destroying value?

5. VALUATION CONTEXT
   - Current P/E vs 5-year average P/E: is the stock cheap, fair, or expensive historically?
   - Current EV/EBITDA vs 5-year average: same comparison
   - What is the implied growth rate in the current stock price?
     (Is the market pricing in more growth than you think is realistic?)

6. OVERALL RATIO VERDICT
   - Top 3 ratio signals that make this company attractive
   - Top 3 ratio signals that are concerning or need watching

I need a thorough management quality assessment for [COMPANY NAME] (NSE: [TICKER]).

1. PROMOTER BACKGROUND AND TRACK RECORD
   - Who are the promoters? First generation founders or inherited business?
   - What is their educational and professional background?
   - Any other businesses they operate? Are those businesses succeeding?
   - Have they ever faced personal legal or regulatory action?

2. SHAREHOLDING AND COMMITMENT SIGNALS
   - Promoter shareholding trend: last 5 years quarterly. Declining? Why?
   - Any pledging? How much? Has it been rising or falling?
   - Any open-market promoter purchases in the last 12 months?
     (Check BSE SAR filings — this is the strongest insider confidence signal)

3. CAPITAL ALLOCATION HISTORY (last 5 years — be specific)
   For each major capital decision (acquisitions, large capex, dividends, buybacks):
   - What was the decision?
   - What was the stated rationale at the time?
   - What was the actual outcome 2-3 years later?
   - Rate each decision: VALUE CREATING / NEUTRAL / VALUE DESTROYING

4. GOVERNANCE RED FLAG CHECKLIST
   - Auditor: name, years in tenure. Any change? If yes, why?
   - Any qualified opinion, emphasis of matter, or other flag in auditor reports?
   - Related party transactions: total value, counterparties, pricing versus market rate
   - Any loans/advances to related parties? Growing or stable?
   - Any SEBI actions, MCA penalties, or court orders?

5. COMMUNICATION QUALITY ASSESSMENT
   Based on the last 4 concall transcripts:
   - Guidance accuracy: build a quarter-by-quarter hit rate table
   - Specificity: do they give numbers or just adjectives?
   - Hard question handling: quote the most evasive exchange you can find
   - Overall transparency: are they more honest in good quarters than bad quarters?

6. FINAL MANAGEMENT RATING
   - Rate management: EXCELLENT / GOOD / AVERAGE / POOR / RED FLAG
   - The one thing about management that gives you the most confidence
   - The one thing about management that concerns you the most

Run a forensic accounting check on [COMPANY NAME] (NSE: [TICKER]).
I am looking for accounting manipulation, earnings inflation, or hidden problems.

Check each of the following areas with specific data:

1. CASH VS PROFIT TEST (the most important test)
   For each of the last 5 years:
   - What is reported PAT?
   - What is actual CFO?
   - CFO / PAT ratio for each year
   Flag: if CFO < 60% of PAT for 2 or more consecutive years = possible earnings inflation

2. RECEIVABLES QUALITY
   - Receivables growth rate vs revenue growth rate for each year
   Flag: if receivables grow faster than revenue for 2+ years = possible fictitious sales or collection problems
   - Provision for doubtful debts: is it growing? Suddenly reversed? (Reversal = possible accounting trick)

3. DEPRECIATION POLICY CHANGES
   - Has the company changed depreciation method or asset useful life in last 5 years?
   - Compare D&A as % of gross fixed assets across all years
   Flag: if D&A / GFA falls suddenly without an explanation = useful life extension = profit inflation

4. RELATED PARTY TRANSACTION ANALYSIS
   - List all material related party transactions from the last 3 annual reports
   - Are the pricing terms disclosed and do they appear to be at market rate?
   Flag: any RPT exceeding 5% of revenue without clear business justification

5. CONTINGENT LIABILITIES
   - What are the disclosed contingent liabilities? Have they grown significantly?
   Flag: contingent liabilities > 20% of net worth without explanation

6. OTHER INCOME PATTERN
   - Is Other Income consistently > 10% of PBT?
   Flag: Core business may be weak, being masked by asset sales or investment income

7. INVENTORY AND RECEIVABLES CHECK
   - Do inventory days and debtor days move together with revenue growth?
   Flag: both rising without revenue growth = possible demand problem or creative accounting

8. OVERALL FORENSIC VERDICT
   - Earnings Quality: HIGH / MEDIUM / LOW
   - Any red flags found? List them with specific years and data
   - Is this company worth deeper investigation, or can you proceed with normal research?

Assess the competitive moat and business quality of [COMPANY NAME] (NSE: [TICKER]).

1. MOAT TYPE IDENTIFICATION
   Test each of the 5 moat types for this company:
   
   A. COST ADVANTAGE: Can this company produce or deliver cheaper than any competitor?
      Evidence: Compare gross margins and COGS structure to peers.
      
   B. NETWORK EFFECTS: Does the product become more valuable as more people use it?
      Evidence: Check if customer acquisition cost falls as user base grows.
      
   C. SWITCHING COSTS: How painful is it for a customer to leave this company?
      Evidence: Customer churn rate, contract lengths, integration depth with customer workflows.
      
   D. INTANGIBLE ASSETS: Does the company own brands, patents, licenses, or regulatory approvals
      that block competition?
      Evidence: Specific brands, patent filings, regulatory approvals.
      
   E. EFFICIENT SCALE: Is the market so small that one player fills demand profitably,
      but a second entrant would destroy margins for both?
      Evidence: Market size vs company revenue.

   VERDICT: Which moat type is STRONGEST for this company? Rate its durability (1-10).

2. MOAT WIDTH ASSESSMENT
   - How wide is the moat? Has it been widening or narrowing over the last 5 years?
   - Evidence for widening: gross margins expanding, market share growing, pricing power improving
   - Evidence for narrowing: new entrants, price pressure, customer concentration increasing

3. COMPETITIVE LANDSCAPE
   - Who are the top 3 competitors? Listed Indian companies only.
   - How does this company compare on: gross margin, ROCE, revenue growth, market share?
   - Is the competitive environment intensifying or stabilising?

4. 10-YEAR DURABILITY TEST
   - Will this moat still be relevant in 10 years?
   - What technology, regulation, or structural change could erode this moat?
   - Probability that moat is still strong in 5 years: ____%

5. MOAT RATING
   - WIDE MOAT: Will persist 20+ years (rare)
   - NARROW MOAT: Will persist 5-10 years (invest if price is right)
   - NO MOAT: Fully commoditised (only invest on very deep value)
   - Which category does this company fall into? Evidence?

Stress-test my valuation of [COMPANY NAME] (NSE: [TICKER]).

CURRENT MARKET PRICE: Rs. [X]
MY BASE CASE FAIR VALUE (from Valuation Model sheet): Rs. [X]
MY ASSUMPTIONS: Revenue growth FY+2: [X]%, EBITDA Margin: [X]%, Target P/E: [X]x

TASK: Run three scenarios and calculate the probability-weighted expected return.

BULL CASE (Probability: 30%)
Assumptions: Revenue grows [X+20]% in FY+1 and FY+2, margin expands 150-200bps,
             P/E re-rates to [X+3]x due to quality re-recognition by market
Calculate: 2-year price target. Return from current price.
What has to go RIGHT for this to happen? Name 2 specific catalysts.

BASE CASE (Probability: 50%)
Assumptions: [Your current assumptions from Valuation Model]
Calculate: 2-year price target. Return from current price.
What is the key assumption this base case depends on most?

BEAR CASE (Probability: 20%)
Assumptions: Revenue grows at half of base case rate, margin contracts 100-150bps,
             P/E compresses to [X-3]x due to growth disappointment
Calculate: 2-year price target. Return from current price. Is this a LOSS scenario?
What has to go WRONG for this to happen? Name 2 specific risks.

PROBABILITY-WEIGHTED RETURN:
= (30% × Bull Return) + (50% × Base Return) + (20% × Bear Return)

FINAL VERDICT:
- Is the probability-weighted return attractive vs your 12% required rate of return?
- What is the WORST CASE downside from current price?
- Are you being adequately compensated for the risk of the bear case?
- FINAL RECOMMENDATION: BUY NOW / WAIT FOR BETTER PRICE / AVOID

I am doing my weekly watchlist review. Here is my current Tier 1 watchlist:

[PASTE YOUR WATCHLIST TABLE — Company, Ticker, Fair Value, Entry Price, Current CMP, MOS%, Thesis Status]

For each Tier 1 company, tell me:

1. PRICE ACTION CONTEXT
   Did the stock move more than 5% this week? If yes, what was the specific reason?
   (Check BSE filings, news, sector development)
   
2. THESIS CHECK
   Has anything happened this week that STRENGTHENS or WEAKENS the investment thesis?
   - Any management interview or investor presentation released?
   - Any regulatory development affecting this sector?
   - Any competitor results that give us read-through on industry trends?

3. BUY ZONE ALERT
   For any company where CMP is now below or within 5% of the entry target:
   - Confirm: Is the price drop due to sentiment (good — buy opportunity) or
     fundamentals (bad — re-examine thesis before buying)?
   - What is the specific action I should take this week?

4. SECTOR DEVELOPMENT CHECK
   Is there any macro or sector news this week that materially changes
   my view on any company in the list?

OUTPUT FORMAT:
For each company: one paragraph with (a) price context, (b) thesis status, (c) specific action.
End with a ranked list: which 1-2 companies are closest to being actionable this week?

I need to update the valuation for [COMPANY NAME] (NSE: [TICKER]).

The company has just announced its Q[X] FY[XX] results.

CURRENT VALUATION RECORD (from my Valuation Tracker sheet):
- Method 1 (P/E): Rs. [X]  |  Used P/E multiple: [X]x
- Method 2 (EV/EBITDA): Rs. [X]  |  Used EV/EBITDA: [X]x
- Method 3 (FCF): Rs. [X]
- Average Fair Value: Rs. [X]
- Entry Price (with MoS): Rs. [X]

LATEST QUARTERLY RESULTS:
[Paste revenue, EBITDA, PAT, key guidance from the latest result press release]

NOW RE-RATE THE VALUATION:

1. DO THE RESULTS CHANGE MY GROWTH ASSUMPTIONS?
   - Original revenue growth assumption: [X]%
   - Should I revise it up or down based on this result? By how much? Why?
   - Original EBITDA margin assumption: [X]%
   - Should I revise it? Evidence from the result?

2. DO THE RESULTS CHANGE MY TARGET MULTIPLES?
   - Is the business quality improving (moat getting stronger) → justify higher multiple?
   - Is execution disappointing (missing guidance) → justify lower multiple?

3. UPDATED FAIR VALUE CALCULATION
   Run all 3 methods with updated assumptions.
   New Method 1 value: Rs. [X]
   New Method 2 value: Rs. [X]
   New Method 3 value: Rs. [X]
   New Average Fair Value: Rs. [X]
   New Entry Price with [X]% MoS: Rs. [X]

4. WHAT CHANGED AND WHY?
   Summarise: did the fair value go up, stay same, or come down from the last estimate?
   What was the biggest driver of the change?

I am monitoring these companies in my watchlist and want to know if any of them
has reached or is approaching an actionable entry point.

MY TIER 1 WATCHLIST:
[Paste: Company | Entry Price Target | Current CMP | MOS% | Thesis Status]

CHECK EACH COMPANY FOR THESE ENTRY TRIGGERS:

TRIGGER 1 — PRICE TRIGGER
Is the CMP within 10% of the entry price target?
If yes: Is the price decline due to business reasons or market sentiment?
(Business reason = re-examine thesis. Market sentiment = potential buy.)

TRIGGER 2 — RESULT TRIGGER
Did the company just report a strong quarterly result where:
- Revenue beat guidance by more than 5%, AND
- Margin expanded vs last quarter, AND
- Management gave positive forward guidance?
If all three yes: this is a quality entry regardless of whether price is at target.

TRIGGER 3 — INSTITUTIONAL ACCUMULATION TRIGGER
Has DII holding increased for 2+ consecutive quarters AND
is the public float (non-promoter, non-institutional) below 25%?
If yes: supply-demand setup becoming favourable — consider a tracking entry.

TRIGGER 4 — SECTOR RE-RATING TRIGGER
Has a positive sector event occurred (PLI announcement, budget allocation,
regulatory clarity) that benefits this company specifically?
If yes: thesis may be strengthening faster than expected. Re-visit valuation upward.

FOR EACH TRIGGERED COMPANY:
- Which trigger fired?
- Recommended action: FULL POSITION / HALF POSITION / TRACKING 5% / CONTINUE WAITING
- Specific condition that must still be met before acting

I am about to invest Rs.[AMOUNT] in [COMPANY NAME] (NSE: [TICKER])
at a price of Rs.[CMP]. Before I execute, challenge my thinking.

MY THESIS SUMMARY:
[Paste your 3-5 sentence thesis from your Thesis Card]

MY VALUATION:
Fair Value: Rs.[X]  |  Entry Price (with MoS): Rs.[X]  |  CMP: Rs.[X]  |  MoS: [X]%

1. DEVIL'S ADVOCATE — BEAR CASE
   Give me the 3 strongest arguments AGAINST this investment right now.
   Be genuinely critical. Do not soften the bear case.
   For each argument: how likely is it, and if it happens, what is the downside to the stock?

2. WHAT AM I MISSING?
   Based on this business and sector, what is the most common mistake analysts make
   when evaluating this type of company?
   Is there any risk specific to Indian markets (regulatory, promoter behavior,
   FX, commodity) that I may have underweighted?

3. TIMING CHECK
   Is there a better entry point likely in the next 3-6 months?
   Examples: results season, sector correction, general market pullback?
   Or is waiting likely to mean I miss the opportunity entirely?

4. BETTER ALTERNATIVES CHECK
   Name 2 companies in the same sector or theme with similar or better quality
   that might currently offer better risk-reward than this one.

5. CONCENTRATION CHECK
   My current portfolio holdings are: [LIST YOUR HOLDINGS + SECTORS]
   Does adding this stock create excessive concentration in any factor:
   sector, theme, export dependency, commodity linkage, or promoter-driven risk?

6. FINAL QUESTION
   If you were investing your own money in this stock at Rs.[CMP] today —
   would you? Give me a straight answer with your reasoning.

If there is any meaningful concern in questions 1-5 above,
recommend I wait, reduce position size, or avoid entirely.

Help me determine the right position size for [COMPANY NAME] (NSE: [TICKER]).

MY PORTFOLIO DETAILS:
- Total Portfolio Size: Rs.[X]
- Current Cash: Rs.[X]
- Current Holdings: [List: Company — % weight — Sector]
- Largest Current Position: [Company] at [X]%

COMPANY DETAILS:
- FA Score from my research: [X] / 10
- Management Score: [X] / 40
- Conviction Level (my assessment): HIGH / MEDIUM / LOW
- Margin of Safety at current price: [X]%
- Stage 3 Valuation: Fair Value Rs.[X], Entry Price Rs.[X], CMP Rs.[X]

ANSWER THESE QUESTIONS:
1. Based on the conviction level and FA score, what % allocation is appropriate?
   Use this framework: FA score 8+ and HIGH conviction = up to 15-20%
                       FA score 7-8 and HIGH conviction = 10-15%
                       FA score 6-7 and MEDIUM conviction = 5-10%
                       FA score below 6 = tracking position only, max 3-5%

2. Should I build this position in one go or in tranches?
   When should I add the second tranche and what condition should trigger it?
   (e.g., "Add second tranche after Q2 FY26 result confirms margin recovery")

3. After this purchase, what will my top 3 largest positions be?
   Is any sector concentration exceeding 30% of my portfolio?

4. What is the absolute maximum rupee loss I should accept on this position
   before exiting? (This becomes my soft stop — not price-based, but thesis-based.)

OUTPUT: Give me a single clear recommendation:
- Buy [X]% of portfolio = Rs.[Y] = approximately [Z] shares at Rs.[CMP]
- Tranche structure (if applicable)
- Maximum acceptable position % ceiling

I am doing my monthly portfolio health check. Here are my current holdings:

[PASTE YOUR LIVE PORTFOLIO TABLE — Company, Ticker, Avg Buy, CMP, P&L%, Weight%, Thesis Status]

MY TOTAL PORTFOLIO:
- Total Invested: Rs.[X]  |  Current Value: Rs.[X]  |  Total Return: [X]%
- Nifty 50 return over same period: [X]%
- Time period of portfolio: [X] months

1. PERFORMANCE ATTRIBUTION
   Which 3 holdings have contributed the MOST to portfolio return?
   Which 3 holdings have HURT the portfolio the most (either losses or large underperformance)?
   Is this outcome due to thesis playing out / not playing out, or just market noise?

2. THESIS HEALTH SCAN
   For every holding marked 'WEAKENING' or 'BROKEN' in my thesis status column:
   - What is the most likely cause of the deterioration?
   - Is this a temporary business issue OR a structural change to the thesis?
   - What specific data point in the NEXT quarterly result would confirm recovery or breakdown?

3. CONCENTRATION RISK
   Looking at my sector allocation:
   - Is any sector above 30% of the portfolio?
   - Am I accidentally concentrated in any theme (export, commodity, regulatory risk, promoter-driven)?
   - What is my biggest single source of risk right now?

4. DEAD WEIGHT IDENTIFICATION
   Is there any holding where: P&L is negative AND thesis is weakening AND
   I would NOT buy it today at the current price?
   If yes — name it. This is a candidate for the exit decision.

5. PORTFOLIO UPGRADE OPPORTUNITY
   Is there any stock currently in my Stage 3 Watchlist that is BETTER QUALITY
   and BETTER PRICED than any current holding?
   If yes, name the potential swap: exit [holding] and enter [watchlist stock].

I am doing my quarterly portfolio review for [QUARTER e.g. Q2 FY26].

All quarterly results are now out. Here is my holdings update:
[PASTE: Company | Quarterly Revenue Growth | EBITDA Margin | PAT vs last year | Mgmt Guidance | My Thesis Status]

For each holding:

1. RESULT QUALITY SCORE (0-10)
   Apply the quarterly scorecard criteria:
   - Revenue vs guidance: 2 points if beat >5%, 1 if in line, 0 if missed
   - Margin trend: 2 points if expanded, 1 if flat, 0 if contracted
   - CFO vs PAT: 2 points if CFO > PAT, 1 if similar, 0 if CFO < PAT
   - Working capital: 2 points if improved, 1 if flat, 0 if deteriorated
   - Guidance quality: 2 points if specific and positive, 1 if vague, 0 if cautious
   Total out of 10.

2. THESIS UPDATE
   For each holding: after this result, is the investment thesis
   (a) STRENGTHENING — execution better than expected
   (b) ON TRACK — meeting expectations
   (c) SLOWING — slightly below expectations but not broken
   (d) BROKEN — fundamental assumption no longer holds

3. PORTFOLIO ACTIONS THIS QUARTER
   Based on all the above, give me a prioritised action list:
   - Add to these positions (and why + how much)
   - Hold these positions (no action required)
   - Put these on watch (one more weak quarter = exit)
   - Exit these positions immediately (thesis broken)

4. NEXT QUARTER WATCHPOINTS
   For each holding: name the ONE specific metric I must track next quarter.
   This becomes my 48-hour research focus when the next result drops.

I need to rebalance my portfolio. Here is the current state:

CURRENT HOLDINGS:
[Paste: Company | Sector | Current Weight % | Original Target Weight % | Thesis Status]

REBALANCING TRIGGERS:
[Check which apply: Position grew >5% above target / Position fell >5% below target /
 New opportunity identified / Thesis changed / Cash need for better opportunity]

ANSWER THESE QUESTIONS:

1. WHAT TO TRIM (if anything)
   Which positions have grown beyond their target weight purely due to price appreciation?
   Is trimming appropriate or should I let winners run?
   Decision rule: trim if position is > 2x its original target AND
                 stock is above 5-year average P/E AND
                 better opportunities exist in watchlist.

2. WHAT TO ADD (if anything)
   Which quality positions have fallen below their target weight due to price weakness
   while the thesis remains INTACT?
   These are add opportunities — falling price + intact thesis = buy more.

3. WHAT TO EXIT (if anything)
   Apply the 4 legitimate exit tests to every holding:
   Test 1: Is the investment thesis still intact? If NO → exit.
   Test 2: Is there 3+ consecutive quarters of revenue decline + margin fall + ROCE fall? If YES → exit.
   Test 3: Is the stock trading above 2x its 5-year average P/E with no step-up in quality? If YES → trim significantly.
   Test 4: Is there a clearly better opportunity in my watchlist with 2x+ upside vs this holding? If YES → consider switching.

4. PORTFOLIO AFTER REBALANCING
   After all proposed actions, what does the portfolio look like?
   Sector weights? Largest position? Cash level?
   Is this a portfolio you would BUILD from scratch today?

I am considering exiting [COMPANY NAME] (NSE: [TICKER]).
Help me make a rigorous, emotion-free exit decision.

MY POSITION:
- Bought at Rs.[X]  |  Current CMP Rs.[X]  |  Return so far: [X]%
- Holding period: [X] months
- Original thesis (paste from Thesis Card): [PASTE]

CURRENT SITUATION:
[Describe what has happened: quarterly results, sector development, management change, etc.]

CHECK ALL 4 EXIT TRIGGERS FOR ME:

TRIGGER 1 — THESIS BROKEN?
- Is the original thesis still valid? Answer yes or no with specific evidence.
- If something has changed — is the change temporary or structural?
- Has the moat actually eroded, or does it just feel that way due to short-term pressure?

TRIGGER 2 — FUNDAMENTAL DETERIORATION?
- Revenue growth: Q-2, Q-1, Latest Quarter — decelerating all 3?
- EBITDA Margin: Q-2, Q-1, Latest Quarter — contracting all 3?
- ROCE: Q-2, Q-1, Latest Quarter — falling all 3?
- All 3 must deteriorate simultaneously for 3+ quarters to trigger this exit.

TRIGGER 3 — VALUATION STRETCHED?
- Current P/E: [X]x vs 5-year average P/E: [X]x
- Is current P/E more than 1.8x the 5-year average?
- Current FCF yield: [X]% — below 1.5%?
- Has the business quality genuinely improved to justify this multiple?

TRIGGER 4 — BETTER OPPORTUNITY?
- Is there a specific stock in my watchlist with at least 2x the expected return?
- Name it and explain the comparison specifically.

FINAL VERDICT:
Based on all 4 triggers — should I EXIT FULL, TRIM (specify %), or HOLD?
Give me a specific, actionable recommendation with your reasoning.

Help me identify if there are better opportunities than my current holdings.

MY CURRENT PORTFOLIO:
[Paste: Company | Current Weight % | Return % | Thesis Status | Expected 3Y Upside % | Quality Score /10]

MY STAGE 3 WATCHLIST — TIER 1 CANDIDATES:
[Paste: Company | Thesis in 1 line | Fair Value | CMP | MoS % | FA Score /10]

ANALYSIS REQUIRED:

1. QUALITY COMPARISON
   For each watchlist candidate, compare directly to the weakest current holding:
   - Is the watchlist stock better quality? (Higher ROCE, better moat, stronger management?)
   - Is the watchlist stock better priced? (More margin of safety, lower vs historical P/E?)
   - What is the expected 3-year return difference between the switch and the hold?

2. UPGRADE CANDIDATES
   Identify any pair where:
   - Watchlist stock quality score > current holding quality score by at least 1 point, AND
   - Watchlist stock expected 3-year return > current holding remaining upside by at least 20%, AND
   - The tax cost of switching does not eliminate the return advantage

3. SWITCH RECOMMENDATION
   For each recommended switch:
   - EXIT: [Current holding] because [specific reason]
   - ENTER: [Watchlist stock] because [specific reason]
   - Expected improvement in portfolio quality: [specific metrics]
   - Expected improvement in expected return: [quantified estimate]

4. WHAT NOT TO DO
   Name any current holding that looks tempting to sell but should actually be held.
   (Sometimes the best action is to do nothing.)

I am doing my annual investment review for [YEAR].

MY PERFORMANCE SUMMARY:
- Portfolio return: [X]%  |  Nifty 50: [X]%  |  Relative: [+/-X]%
- Buys made: [X]  |  Sells made: [X]
- Current portfolio: [list all holdings with return %]

MY COMPLETED EXITS THIS YEAR:
[List: Company | Buy Price | Sell Price | Return % | Exit Trigger Used]

PLEASE AUDIT MY YEAR:

1. DECISION QUALITY REVIEW (most important section)
   For each buy I made this year:
   - Was the entry based on a complete thesis or a shortcut?
   - Did the stock perform as the thesis predicted?
   - If not — was the thesis wrong or was execution poor?

   For each sell I made this year:
   - Was it based on one of the 4 legitimate triggers?
   - Or was it emotional (fear, FOMO, impatience)?
   - What was the outcome of the sell? Was it the right decision?

2. BIAS IDENTIFICATION
   Looking at my decisions across the full year:
   - Did I hold losers too long (loss aversion)?
   - Did I sell winners too early (premature profit booking)?
   - Did I chase any stocks after they had already run up?
   - Was I over-influenced by external opinions vs my own research?

3. PROCESS ADHERENCE
   On a scale of 1-10, how consistently did I follow the 6-stage system?
   Which stage was my biggest weakness this year?

4. PORTFOLIO QUALITY TODAY
   Is the current portfolio the best version of itself?
   Which holding is the weakest and why?
   Which holding has the most potential and why?

5. THREE SPECIFIC ACTIONS FOR NEXT YEAR
   Not vague goals. Three specific, measurable changes to my process or portfolio.